- Home
- ELVN vs IRS Comparison
ELVN vs IRS Comparison
Compare ELVN & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- IRS
- Stock Information
- Founded
- ELVN 2016
- IRS 1943
- Country
- ELVN United States
- IRS Argentina
- Employees
- ELVN N/A
- IRS N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- ELVN Health Care
- IRS Real Estate
- Exchange
- ELVN Nasdaq
- IRS Nasdaq
- Market Cap
- ELVN 1.2B
- IRS 1.1B
- IPO Year
- ELVN 2020
- IRS 1994
- Fundamental
- Price
- ELVN $22.63
- IRS $14.11
- Analyst Decision
- ELVN Strong Buy
- IRS Strong Buy
- Analyst Count
- ELVN 5
- IRS 1
- Target Price
- ELVN $41.20
- IRS $12.62
- AVG Volume (30 Days)
- ELVN 721.5K
- IRS 162.8K
- Earning Date
- ELVN 08-12-2025
- IRS 09-02-2025
- Dividend Yield
- ELVN N/A
- IRS 7.08%
- EPS Growth
- ELVN N/A
- IRS N/A
- EPS
- ELVN N/A
- IRS 0.20
- Revenue
- ELVN N/A
- IRS $308,539,877.00
- Revenue This Year
- ELVN N/A
- IRS N/A
- Revenue Next Year
- ELVN N/A
- IRS N/A
- P/E Ratio
- ELVN N/A
- IRS $6.57
- Revenue Growth
- ELVN N/A
- IRS N/A
- 52 Week Low
- ELVN $13.30
- IRS $7.93
- 52 Week High
- ELVN $30.03
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- ELVN 60.45
- IRS 45.32
- Support Level
- ELVN $19.38
- IRS $14.06
- Resistance Level
- ELVN $21.34
- IRS $14.74
- Average True Range (ATR)
- ELVN 1.27
- IRS 0.56
- MACD
- ELVN 0.11
- IRS 0.04
- Stochastic Oscillator
- ELVN 88.47
- IRS 45.14
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.